Novartis AGNOVN:VTX

71.25
0.20 / 0.28%
3.37m
44.00%
0.739
Close in CHFToday's changeShares traded1 year changeBeta
As of May 24 2013 16:31 BST.Data delayed by at least 15 minutes.

Summary

On Friday, Novartis AG (NOVN:VTX) closed at 71.25, 3.39% below its 52-week high of 73.75, set on May 22, 2013.

52-week range
Today
48.89
May 24 2012
73.75
May 22 2013
Markit short selling activity
Low
Medium
High
Open71.35
Day high71.95
Day low71.05
Bid71.25
Offer71.30
Previous close71.45
Average volume4.79m
Shares outstanding2.71bn
Free float2.50bn
P/E (TTM)18.79
Market cap191.52bn CHF
EPS (TTM)3.77 CHF
Annual div (TTM)1.50 CHF
Annual div yield (TTM)2.09%
Div ex-dateFeb 26 2013
Div pay-dateMar 01 2013
Last IC View
The last IC recommendation on Novartis AG shares was Buy at 50.00 on 04 May 2012
Read the full article

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Novartis AG-0.70%+3.26%+26.44%+44.00%+29.45%
ALL SHARE CH X INDEX-1.29%+3.86%+20.82%+36.43%+4.53%
CH/HEALTH CARE+0.80%+5.88%+24.99%+35.12%--
CH/PHARMACEUTICALS+0.92%+5.94%+25.24%+35.45%--
As of May 24 2013 16:31 BST.Data delayed by at least 15 minutes.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.